“新冠”疫情英语新闻语法填空10篇(四)(word版)-20211111070602.docx-原创力文档
PAGE
PAGE #
r 、 、 、
\\
x X x X. x
XXXXXXXX x
“新冠”疫情英语新闻 语法填空10篇 （四）（word 版）
-CAL-FENGHAI..(YICAI)-Company One 1
高中“新冠”疫情英语新闻语法填空10篇（四）
I. Three Chinese Vaccines against COVID-19 are on the Way 三种针对 COVID-19 的中国疫 苗正在研制中
According to the latest news from Science and Technology Daily (April 14th), two COVID-19 inactivated vaccines were just approved for a phase I & II 1 (combine)
clinical trial by the National Medical Products Administration (NMPA) of China, making them the first batch in this category.2 two vaccines were developed respectively by
Wuhan Institute of Biological Products Co., Ltd of Sinopharm and Sinovac Research & Development Co., Ltd together with research institutes.This is another piece of good news since the team of Chen Wei, academician at China Academy of Engineering and researcher at Academy of Military Medical Sciences, managed to get clinical trial 3(approve) for
the recombinant COVID-19 vaccine they developed on March 17th.
Vaccine is not a distant solution for a current emergency,4 rather the most
powerful weapon to defeat COVID-19.China made the decision to accelerate the pace 5(base)on rational judgement and organization with the premise of safety assurance. As early on January 21st, the Ministry of Science and Technology (MOST) announced the 6(establish)of an expert group of joint epidemic prevention and
control against COVID-19. The expert group was led by Zhong Nanshan, academician at China Academy of Engineering, and consisted of 14 experts. On 22nd, the first eight emergency programs of Scientific Response to COVID-19 were initiated 7
(swift).Since the start of the program, Chen Wei's team 8(conduct) research on
recombinant COVID-19 vaccine (adenovirus vector vaccine) based on the successful experience in Ebola vaccine development with great speed. On March 17thz the team's recombinant COVID-19 vaccine was approved for clinical trial,9 took place one
month in advance than expected. By April 2nd, all 108 subject
